Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

1,700

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

October 31, 2012

Conditions
Coronary Artery Disease
Interventions
DRUG

clopidogrel treatment after bare metal stent implantation

extending use of clopidogrel on top of aspirin up to 24 months after coronary implantation of bare metal stent

DRUG

clopidogrel treatment after bare metal stent implantation

Adding clopidogrel on top of Aspirin according to the practice suggested by Italian national institute of health, i.e. 1 month after BMS implantation.

DRUG

clopidogrel after zotarolimus-eluting stent implantation

extending use of clopidogrel on top of aspirin up to 24 months after coronary implantation of zotarolimus-eluting stent coronary implantation

DRUG

clopidogrel after paclitaxel-eluting stent implantation

extending use of clopidogrel on top of aspirin up to 24 months after coronary implantation of paclitaxel-eluting stent

DRUG

clopidogrel after everolimus-eluting stent implantation

extending use of clopidogrel on top of aspirin up to 24 months after coronary implantation of Everolimus-eluting stent

DRUG

clopidogrel after zotarolimus-eluting stent implantation

Adding clopidogrel on top of Aspirin according to the practice suggested by Italian national institute of health, i.e. 6 month after DES implantation.

DRUG

clopidogrel after paclitaxel-eluting stent implantation

Adding clopidogrel on top of Aspirin according to the practice suggested by Italian national institute of health, i.e. 6 month after DES implantation.

DRUG

clopidogrel after everolimus-eluting stent implantation

Adding clopidogrel on top of Aspirin according to the practice suggested by Italian national institute of health, i.e. 6 month after DES implantation.

Trial Locations (1)

44100

Azienda Ospedaliera Universitaria di Ferrara, Ferrara

All Listed Sponsors
lead

Marco Valgimigli

OTHER

NCT00611286 - Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter